Cargando…

Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth

BACKGROUND: ZNF331 was reported to be a transcriptional repressor. Methylation of the promoter region of ZNF331 has been found frequently in human esophageal and gastric cancers. The function and methylation status of ZNF331 remain to be elucidated in human colorectal cancer (CRC). METHODS: Six colo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuzhu, He, Tao, Herman, James G., Linghu, Enqiang, Yang, Yunsheng, Fuks, François, Zhou, Fuyou, Song, Linjie, Guo, Mingzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648453/ https://www.ncbi.nlm.nih.gov/pubmed/29075358 http://dx.doi.org/10.1186/s13148-017-0417-4

Ejemplares similares

Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
por: Wang, Yuzhu, et al.
Publicado: (2018)

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2018)

RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel
por: Guo, Jing, et al.
Publicado: (2015)

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
por: Marie Vedeld, Hege, et al.
Publicado: (2015)

Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis
por: Zheng, Ruipan, et al.
Publicado: (2017)

Association of ZNF331 and WIF1 methylation in peripheral blood leukocytes with the risk and prognosis of gastric cancer
por: Nie, Chuang, et al.
Publicado: (2021)

Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer
por: Yan, Wenji, et al.
Publicado: (2018)

Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer
por: Jia, Yan, et al.
Publicado: (2015)

Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
por: Li, Hongxia, et al.
Publicado: (2018)

Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel
por: Yun, Tianyang, et al.
Publicado: (2015)

Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development
por: Wang, Ying, et al.
Publicado: (2017)

Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling
por: Zhang, Meiying, et al.
Publicado: (2016)

Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
por: Guo, Yulin, et al.
Publicado: (2017)

ZNF3 regulates proliferation, migration and invasion through MMP1 and TWIST in colorectal cancer: ZNF3 regulates proliferation, migration and invasion in colorectal cancer
por: Du, Le, et al.
Publicado: (2022)

Serum oxidative stress is an independent prognostic marker in colorectal cancer
por: Sugimoto, Kiichi, et al.
Publicado: (2019)

Expression of ZNF281 in colorectal cancer correlates with response to radiotherapy and survival
por: Qin, Changjiang, et al.
Publicado: (2023)

Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis
por: Liu, Jiaxin, et al.
Publicado: (2021)

DNA methylation markers for breast cancer prognosis: Unmasking the immune component
por: Dedeurwaerder, Sarah, et al.
Publicado: (2012)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer
por: Kitakaze, Masatoshi, et al.
Publicado: (2023)

Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer
por: Gimeno-Valiente, Francisco, et al.
Publicado: (2021)

Targeted DNA demethylation of the ZNF334 promoter inhibits colorectal cancer growth
por: Yang, Bin, et al.
Publicado: (2023)

Prognostic markers for colorectal cancer
por: Tyrrell, Helen E.J., et al.
Publicado: (2018)

Epigenetic changes in colorectal cancer
por: Jia, Yan, et al.
Publicado: (2013)

Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma
por: Chen, Changbao, et al.
Publicado: (2021)

CD133 expression is an independent prognostic marker for low survival in colorectal cancer
por: Horst, D, et al.
Publicado: (2008)

Expression of circZNF609 is Down-Regulated in Colorectal Cancer Tissue and Promotes Apoptosis in Colorectal Cancer Cells by Upregulating p53
por: Zhang, Xiaoyun, et al.
Publicado: (2019)

MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
por: Li, Zewu, et al.
Publicado: (2015)

Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
por: Draht, Muriel X. G., et al.
Publicado: (2018)

DNA-methylated gene markers for colorectal cancer in TCGA database
por: Zhang, Hui, et al.
Publicado: (2020)

Downregulation of ZNF365 by methylation predicts poor prognosis in patients with colorectal cancer by decreasing phospho-p53 (Ser15) expression
por: Wang, Chan, et al.
Publicado: (2020)

MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer
por: Gemoll, Timo, et al.
Publicado: (2015)

Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer
por: Schölch, Sebastian, et al.
Publicado: (2019)

High expression of NOLC1 as an independent prognostic factor for survival in patients with colorectal cancer
por: Sun, Zhiwei, et al.
Publicado: (2023)

Retraction: MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
Publicado: (2020)

Cancer stem cell marker expression and methylation status in patients with colorectal cancer
por: Mersakova, Sandra, et al.
Publicado: (2022)

SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers
por: Jang, Bo Gun, et al.
Publicado: (2020)

Clinical Implications of Systemic Inflammatory Response Markers as Independent Prognostic Factors in Colorectal Cancer Patients
por: Paik, Kwang Yeol, et al.
Publicado: (2014)

Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
por: Melling, Nathaniel, et al.
Publicado: (2015)

Long-term follow-up of nonspecific small bowel ulcers with a benign course and no requirement for surgery: is this a distinct group?
por: Wang, Weifeng, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vm0dadm3o4ma0oi2u6m0jo1580